Bio-Rad Laboratories, Inc. (BIO): Total Liabilities
$3.12B
As of 2025-12-31
$3.08B
As of 2026-06-30
-7.0%
3-year compound annual growth
+0.2%
5-year compound annual growth
+9.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.12B | +11.7% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $2.79B | -21.4% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $3.56B | -8.5% | 2025-02-14, Balance as of period end |
| 2022-12-31 | $3.89B | -5.5% | 2024-02-16, Balance as of period end |
| 2021-12-31 | $4.11B | +33.0% | 2023-02-17, Balance as of period end |
| 2020-12-31 | $3.09B | +37.2% | 2022-02-11, Balance as of period end |
| 2019-12-31 | $2.25B | +41.7% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $1.59B | +18.5% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $1.34B | +5.6% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $1.27B | +4.3% | 2018-04-16, Balance as of period end |
| 2015-12-31 | $1.22B | +5.5% | 2017-03-01, Balance as of period end |
| 2014-12-31 | $1.16B | -3.8% | 2016-02-29, Balance as of period end |
| 2013-12-31 | $1.20B | -15.8% | 2015-03-02, Balance as of period end |
| 2012-12-31 | $1.43B | +5.6% | 2014-03-18, Balance as of period end |
| 2011-12-31 | $1.35B | -11.2% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $1.52B | +21.1% | 2012-02-29, Balance as of period end |
| 2009-12-31 | $1.26B | n/a | 2011-02-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $3.12B | +11.7% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $4.92B | +4.1% |
| Waters Corp (WAT) | 2025-12-31 | $2.52B | -7.7% |
| Bruker Corp (BRKR) | 2025-12-31 | $3.73B | -6.5% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $3.74B | +11.0% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $6.23B | +1.2% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $5.99B | +0.6% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $245.04M | +17.5% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $119.80M | +15.5% |
Compare BIO, RVTY, WAT, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗